Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$117.93B
Total volume
BTC 49.84%     ETH 15.30%
Dominance

Astellas Pharma Inc. ALPMY Stock

10.75 USD {{ price }} -1.736742% {{change_pct}}%
Exchange
Other OTC
Market Cap
19.68B USD
LOW - HIGH [24H]
10.71 - 11.03 USD
VOLUME [24H]
295.56K USD
{{ volume }}
P/E Ratio
537.50
Earnings per share
0.02 USD

Astellas Pharma Inc. Price Chart

Astellas Pharma Inc. ALPMY Financial and Trading Overview

Astellas Pharma Inc. stock price 10.75 USD
Previous Close 16.33 USD
Open 16.18 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 16.04 - 16.18 USD
52 Week Range 12.82 - 16.91 USD
Volume 47.27K USD
Avg. Volume 59.4K USD
Market Cap 29.16B USD
Beta (5Y Monthly) 0.537164
PE Ratio (TTM) 29.851852
EPS (TTM) 0.02 USD
Forward Dividend & Yield 0.44 (2.67%)
Ex-Dividend Date March 30, 2023
1y Target Est 17.09 USD

ALPMY Valuation Measures

Enterprise Value -272288628736 USD
Trailing P/E 29.851852
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.01920099
Price/Book (mrq) 0.019344984
Enterprise Value/Revenue -0.179
Enterprise Value/EBITDA -0.731

Trading Information

Astellas Pharma Inc. Stock Price History

Beta (5Y Monthly) 0.537164
52-Week Change 10.33%
S&P500 52-Week Change 20.43%
52 Week High 16.91 USD
52 Week Low 12.82 USD
50-Day Moving Average 15.59 USD
200-Day Moving Average 14.65 USD

ALPMY Share Statistics

Avg. Volume (3 month) 59.4K USD
Avg. Daily Volume (10-Days) 45.43K USD
Shares Outstanding 1.81B
Float 1.79B
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.029%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 60
Trailing Annual Dividend Yield 367.42%
5 Year Average Dividend Yield 247.00%
Payout Ratio 0.739
Last Split Factor 125:100

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 6.50%
Operating Margin (ttm) 17.55%
Gross Margin 81.01%
EBITDA Margin 24.52%

Management Effectiveness

Return on Assets (ttm) 6.95%
Return on Equity (ttm) 6.65%

Income Statement

Revenue (ttm) 1.52T USD
Revenue Per Share (ttm) 834.4 USD
Quarterly Revenue Growth (yoy) 16.60%
Gross Profit (ttm) N/A
EBITDA 372.4B USD
Net Income Avi to Common (ttm) 98.71B USD
Diluted EPS (ttm) 0.54
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 376.84B USD
Total Cash Per Share (mrq) 208.24 USD
Total Debt (mrq) 75B USD
Total Debt/Equity (mrq) 4.97 USD
Current Ratio (mrq) 1.446
Book Value Per Share (mrq) 833.291

Cash Flow Statement

Operating Cash Flow (ttm) 327.77B USD
Levered Free Cash Flow (ttm) 216.46B USD

Profile of Astellas Pharma Inc.

Country United States
State N/A
City Tokyo
Address 2-5-1, Nihonbashi-Honcho
ZIP 103-8411
Phone 81 3 3244 3000
Website https://www.astellas.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees N/A

Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals in the Japan, United States, and internationally. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a beta-3 adrenergic receptor agonist for the treatment of overactive bladder urgency, urinary frequency, and urge urinary incontinence; Evrenzo, an oral treatment for anemia associated with chronic kidney disease; and Prograf and Advagraf/Graceptor/ASTAGRAF, which are immunosuppressants used to suppress organ rejection following a transplant. The company has a joint research agreement with Veneno Technologies Co. Ltd. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan.

Q&A For Astellas Pharma Inc. Stock

What is a current ALPMY stock price?

Astellas Pharma Inc. ALPMY stock price today per share is 10.75 USD.

How to purchase Astellas Pharma Inc. stock?

You can buy ALPMY shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Astellas Pharma Inc.?

The stock symbol or ticker of Astellas Pharma Inc. is ALPMY.

Which industry does the Astellas Pharma Inc. company belong to?

The Astellas Pharma Inc. industry is Drug Manufacturers-General.

How many shares does Astellas Pharma Inc. have in circulation?

The max supply of Astellas Pharma Inc. shares is 1.83B.

What is Astellas Pharma Inc. Price to Earnings Ratio (PE Ratio)?

Astellas Pharma Inc. PE Ratio is 537.50000000 now.

What was Astellas Pharma Inc. earnings per share over the trailing 12 months (TTM)?

Astellas Pharma Inc. EPS is 0.02 USD over the trailing 12 months.

Which sector does the Astellas Pharma Inc. company belong to?

The Astellas Pharma Inc. sector is Healthcare.